Clinical Trial Update: Immunoadsorption Versus Plasma Exchange for Treatment of Guillain-Barré Syndrome (GBS)

View source ↗

Summary

This clinical trial compares immunoadsorption versus plasma exchange for Guillain-Barré syndrome and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Guillain-barré Syndrome

Drugs mentioned

• Immunoadsorption
• Plasma exchange

Snippet

Sponsor: University of Ulm | Conditions: GBS | Status: RECRUITING